TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Paragon Care Limited ( (AU:PGC) ) has shared an update.
Paragon Care Limited has announced its acquisition of Haju Medical, a leading provider of medical aesthetic services and technology in Indonesia. This strategic acquisition is expected to enhance Paragon Care’s presence in the Asia Pacific region and complement its existing business operations in Thailand and other emerging markets. The acquisition, valued at A$70 million, is anticipated to be earnings accretive for Paragon Care in FY26 and will be funded through existing working capital facilities. The completion of the acquisition is expected by January 2026, subject to customary conditions.
The most recent analyst rating on (AU:PGC) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Paragon Care Limited stock, see the AU:PGC Stock Forecast page.
More about Paragon Care Limited
Paragon Care Limited is an Australian-based company in the healthcare sector, providing medical equipment, devices, consumables, pharmaceuticals, complementary medicines, nutritional supplies, and manufacturing Blood Bank diagnostic reagents for healthcare markets in Australia, New Zealand, and Asia.
YTD Price Performance: -38.54%
Average Trading Volume: 529,094
Technical Sentiment Signal: Sell
Current Market Cap: A$488.3M
Learn more about PGC stock on TipRanks’ Stock Analysis page.